Yüklüyor......
二线不同化疗方案治疗小细胞肺癌的疗效和安全性比较
BACKGROUND AND OBJECTIVE: Small-cell lung cancer (SCLC) is an aggressive disease for which the mainstay of treatment is cytotoxic chemotherapy. Despite good initial responses most patients will relapse or progress after the first-line therapy. The evidence of a benefit from second-line chemotherapy...
Kaydedildi:
| Yayımlandı: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
中国肺癌杂志编辑部
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015214/ https://ncbi.nlm.nih.gov/pubmed/25975298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2015.05.05 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|